Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005334946 | SCV005991215 | uncertain significance | Inborn genetic diseases | 2024-12-16 | criteria provided, single submitter | clinical testing | The c.2342G>A (p.G781E) alteration is located in exon 4 (coding exon 4) of the EMILIN1 gene. This alteration results from a G to A substitution at nucleotide position 2342, causing the glycine (G) at amino acid position 781 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |